TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA)

Clinical trials for TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA) explained in plain language.

Never miss a new study

Get alerted when new TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA) trials appear

Sign up with your email to follow new studies for TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists hunt for DNA clues to target prostate cancer treatment

Knowledge-focused Recruiting now

This study aims to identify molecular markers in tumor DNA that can predict which patients with advanced, treatment-resistant prostate cancer will respond to a targeted radiation therapy called Lu-PSMA. Researchers will analyze tumor samples from 120 men already scheduled to rece…

Matched conditions: TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA)

Phase: NA • Sponsor: Centre Jean Perrin • Aim: Knowledge-focused

Last updated Apr 02, 2026 04:26 UTC

TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA)

Get alerted when new TREATED BY 177LUTETIUM-PSMA-617 (LU-PSMA) trials appear

Scientists hunt for DNA clues to target prostate cancer treatment